TY - JOUR
T1 - Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases
AU - Terao, Chikashi
AU - Yoshifuji, Hajime
AU - Yamano, Yoshihisa
AU - Kojima, Hiroto
AU - Yurugi, Kimiko
AU - Miura, Yasuo
AU - Maekawa, Taira
AU - Handa, Hiroshi
AU - Ohmura, Koichiro
AU - Saji, Hiroh
AU - Mimori, Tsuneyo
AU - Matsuda, Fumihiko
N1 - Publisher Copyright:
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Objective. To uncover the genetic background of relapsing polychondritis (RPC), a rare autoimmune disease with unknown mechanisms characterized by systemic inflammation of the cartilage, to deepen our understanding of the pathophysiology of RPC and show its distinct genetic characteristics from other rheumatic diseases.Methods. A total of 102 patients with RPC and 1000 healthy subjects were recruited for a two-staged genetic association study and genotyped for six HLA classical loci. Haplotype association tests were also performed. The associations of amino acid (AA) residues and positions with susceptibility to RPC were analysed. Frequencies of representative susceptibility HLA alleles to other rheumatic diseases in RPC were also analysed.Results. HLA-DRB1*16:02, HLA-DQB1*05:02 and HLA-B*67:01, which are in linkage disequilibrium with each other, were associated with RPC (P = 1.9 × 10-6, 1.4 × 10-5 and 0.00024, respectively). AA residue at position 57 in HLA-DQB1, the most significant position in type I diabetes mellitus, showed the strongest association among AA residues. HLA-DR4, a known susceptibility allele in Germans, showed a trend of susceptibility association without significance (P = 0.067). No associations were observed between the three alleles and clinical phenotypes. Representative susceptibility HLA alleles to RA, SLE, Behçet disease and Takayasu arteritis did not show enrichment in RPC in spite of sufficient statistical power.Conclusions. HLA-DRB1*16:02, HLA-DQB1*05:02 and HLA-B*67:01, in linkage disequilibrium with each other, are associated with susceptibility to RPC Importance of HLA-class II loci in RPC susceptibility is suggested. RPC is considered a genetically distinct disease from other rheumatic diseases.
AB - Objective. To uncover the genetic background of relapsing polychondritis (RPC), a rare autoimmune disease with unknown mechanisms characterized by systemic inflammation of the cartilage, to deepen our understanding of the pathophysiology of RPC and show its distinct genetic characteristics from other rheumatic diseases.Methods. A total of 102 patients with RPC and 1000 healthy subjects were recruited for a two-staged genetic association study and genotyped for six HLA classical loci. Haplotype association tests were also performed. The associations of amino acid (AA) residues and positions with susceptibility to RPC were analysed. Frequencies of representative susceptibility HLA alleles to other rheumatic diseases in RPC were also analysed.Results. HLA-DRB1*16:02, HLA-DQB1*05:02 and HLA-B*67:01, which are in linkage disequilibrium with each other, were associated with RPC (P = 1.9 × 10-6, 1.4 × 10-5 and 0.00024, respectively). AA residue at position 57 in HLA-DQB1, the most significant position in type I diabetes mellitus, showed the strongest association among AA residues. HLA-DR4, a known susceptibility allele in Germans, showed a trend of susceptibility association without significance (P = 0.067). No associations were observed between the three alleles and clinical phenotypes. Representative susceptibility HLA alleles to RA, SLE, Behçet disease and Takayasu arteritis did not show enrichment in RPC in spite of sufficient statistical power.Conclusions. HLA-DRB1*16:02, HLA-DQB1*05:02 and HLA-B*67:01, in linkage disequilibrium with each other, are associated with susceptibility to RPC Importance of HLA-class II loci in RPC susceptibility is suggested. RPC is considered a genetically distinct disease from other rheumatic diseases.
UR - http://www.scopus.com/inward/record.url?scp=84995564761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995564761&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/kew233
DO - 10.1093/rheumatology/kew233
M3 - Article
C2 - 27241705
AN - SCOPUS:84995564761
SN - 1462-0324
VL - 55
SP - 1686
EP - 1692
JO - Rheumatology (United Kingdom)
JF - Rheumatology (United Kingdom)
IS - 9
M1 - kew233
ER -